WooGeneB&G
At a glance
WooGeneB&G filed 46 disclosures in the last 12 months, including 11 insider, 9 5% holder and 1 issuance. The most recent key filing was on Sep 30: CEO bought 35,358 sh on the market at an average ₩2,867, Sep 28.
Revenue for 2025 was ₩54.8B, down 1.6% on 2024. Operating margin was 0.6% against 0.5% a year earlier. Debt was 71% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩29.8B and operating profit of ₩2.1B.
The 2025 annual report lists 103 employees with an average tenure of 10.3 years and average pay of ₩54.2M, #1489 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩112.5M each on average. It paid no cash dividend for 2025. 강재구 and related parties held 23.26% at year end.
Of 5 recent 5%+ holder reports, 5 raised and 0 cut a stake; the largest stake reported was 31.50% on Sep 30.
From the 2025 annual report
Staff: 103 (76 men, 27 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩5.6B. Directors and auditors: 5, paid ₩562.4M in total.
No cash dividend was paid for 2025.
Largest shareholder
강재구 holds 14.65%; with 7 related parties the group holds 23.26% of common shares at year end.
Auditor: 도원회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
5%+ holder reports
Key filings
Other filings
Links open the original filing on DART, in Korean.